Xuefeng Yu | Chief Executive Officer
CanSino Biologics Inc.

Xuefeng Yu, Chief Executive Officer, CanSino Biologics Inc.

Dr. Xuefeng Yu has been the Co-founder, Chairman and CEO of CANSINO BIOLOGICS INC since 2009. He brings more than 30 years of experience in research, development and commercialization of advanced vaccine for human use. After obtaining his PhD in microbiology from McGill University (Quebec, Canada) in 1998, Dr. Yu joined Sanofi Pasteur and held a significant position of director in Canada for over 10 years.

Appearances:



Day 2, April 8 @ 12:10

CanSino’s adenovirus-based viral vector technology platform and its applications in vaccine development

last published: 21/Feb/20 16:35 GMT
last published: 21/Feb/20 16:35 GMT
last published: 21/Feb/20 16:35 GMT
last published: 21/Feb/20 16:35 GMT
last published: 21/Feb/20 16:35 GMT
last published: 21/Feb/20 16:35 GMT
last published: 21/Feb/20 16:35 GMT
last published: 21/Feb/20 16:35 GMT
last published: 21/Feb/20 16:35 GMT
last published: 21/Feb/20 16:35 GMT
last published: 21/Feb/20 16:35 GMT

back to speakers